Zealand Pharma A/S (22Z1)
Market Open
11 Aug, 13:26
XFRA XFRA Primary €
8. 50
+0.2
+2.4096%
€
2.87B Market Cap
- P/E Ratio
- Div Yield
0 Volume
0.28 Eps
€ 8.3
Previous Close Want to track 22Z1 and more in your Portfolio? 🎯
Sign up for Marketlog, a portfolio tracker that will exceed your expectations!
Zealand Pharma A/S (22Z1) Statistics
Valuation metrics
Market Cap 2.87B
Enterprise value -1.81B
Trailing P/E (ttm) 3.35
Forward P/E -
PEG ratio 0.19
Price/Sales (ttm) 0.3
Price/Book (mrq) 1.46
Enterprise Value/Revenue -1.46
Enterprise Value/EBITDA -1.98
Overview
Shares outstanding 70.66M
Float 56.75M
Shares short -
% Held by insiders -
% Held by institutions -
Average volume (10 days) -
Average volume (90 days) -
Price summary
52-Week low 6
52-Week high 13.9
Beta 0.56
50-Day moving average 7.67
200-Day moving average 10.41
Financials
Fiscal year
Fiscal year ends 31 Dec 2025
Most recent quarter (mrq) 31 Mar 2026
Profitability
Profit margin 0.69%
Operating margin -15.85%
Operational effectiveness
Return on assets 0.35%
Return on equity 0.56%
Income Statement
Revenue (ttm) 1.24B
Revenue per share (ttm) 26.22
Quarterly revenue growth (yoy) 3.25%
Gross profit (ttm) 1.24B
EBITDA 7.15B
Net income to common (ttm) 856.11M
Diluted EPS (ttm) 2.39
Quarterly earnings growth (yoy) 3.2%
Balance Sheet
Total cash (mrq) 1.94B
Total cash per share (mrq) 204.75
Total debt (mrq) 55.41M
Total Debt/Equity (mrq) 2.86
Current ratio (mrq) 37.17%
Book value per share (mrq) 5.48
Cash Flow
Cash flow statement 851.41M
Levered free cash flow (LFCF) 565.41M
